A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder - Concepedia

Concepedia

Publication | Open Access

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

DOI Full Paper Access

613

Citations

20

References

1991

Year

Donald L. Lamm, Brent A. Blumenstein, E. David Crawford, James E. Montie, Peter T. Scardino, H. Barton Grossman, Thomas H. Stanisic, Joseph A. Smith, Michael F. Sarosdy

New England Journal of Medicine

Abstract

As compared with intravesical doxorubicin, immunotherapy with BCG provides improved protection against the recurrence of superficial bladder cancer.

References

	Year	Citations

Page 1